From a therapeutic point of view, it was recently shown that the pharmacological inhibition of DRP1 in PC cells and mice by treatment with Mdivi-1, a DRP1 inhibitor [142], induces mitochondrial fusion and decreases tumor growth and lung metastases. Here, DNM1L is linked to pachyonychia congenita.